GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » EKIMAS Corp (OTCPK:ASNB) » Definitions » 10-Year RORE %

EKIMAS (EKIMAS) 10-Year RORE % : 0.00% (As of Dec. 2022)


View and export this data going back to 1996. Start your Free Trial

What is EKIMAS 10-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. EKIMAS's 10-Year RORE % for the quarter that ended in Dec. 2022 was 0.00%.

The industry rank for EKIMAS's 10-Year RORE % or its related term are showing as below:

ASNB's 10-Year RORE % is not ranked *
in the Diversified Financial Services industry.
Industry Median: -3.285
* Ranked among companies with meaningful 10-Year RORE % only.

EKIMAS 10-Year RORE % Historical Data

The historical data trend for EKIMAS's 10-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKIMAS 10-Year RORE % Chart

EKIMAS Annual Data
Trend Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22
10-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.78 -22.48 -305.92 471.28 42.94

EKIMAS Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
10-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 73.41 42.94 16.44 9.67 17.27

Competitive Comparison of EKIMAS's 10-Year RORE %

For the Shell Companies subindustry, EKIMAS's 10-Year RORE %, along with its competitors' market caps and 10-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKIMAS's 10-Year RORE % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, EKIMAS's 10-Year RORE % distribution charts can be found below:

* The bar in red indicates where EKIMAS's 10-Year RORE % falls into.



EKIMAS 10-Year RORE % Calculation

EKIMAS's 10-Year RORE % for the quarter that ended in Dec. 2022 is calculated as:

10-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 10-year -Cumulative Dividends per Share for 10-year )
=( -1.059--2 )/( 5.45-0 )
=0.941/5.45
=17.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 10-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2022 and 10-year before.


EKIMAS  (OTCPK:ASNB) 10-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 10-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


EKIMAS 10-Year RORE % Related Terms

Thank you for viewing the detailed overview of EKIMAS's 10-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


EKIMAS (EKIMAS) Business Description

Traded in Other Exchanges
N/A
Address
3651 Lindell Road, Suite D565, Las Vegas, NV, USA, 89103
EKIMAS Corp is a shell company.
Executives
Partners Aps Gk 10 percent owner MESTERLODDEN 3B, GENTOFTE G7 2820
Henrik Oerbekker 10 percent owner 94, RUE DES AUBEPINES, L-1145, LUXEMBOURG N4 2449
Henrik Rouf 10 percent owner 468 N. CAMDEN DR., SUITE 350, BEVERLY HILLS CA 90210
Khristine L Carroll officer: EVP Commercial Operations 229 ANDOVER STREET, WILMINGTON MA 01887
Michael F Adams director, officer: Chief Executive Officer 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
David Crispino Volpe officer: Chief Financial Officer 235 STONEBRIDGE DRIVE, NASHUA NH 03063
Michael L Barretti director 78 E OLYMPIA AVE, C/O CARDIO TECH INTERNATIONAL INC, WOBURN MA 01810-2057
Oneill William J Jr director 4000 HOLLYWOOD BLVD STE 650N, HOLLYWOOD FL 33021
Mark R Tauscher director
Eric G Walters officer: Vice President and CFO C/O MFIC CORP, 30 OSSIPEE RD., NEWTON MA 02464
Andrew Martin Reed officer: VP of Science and Technology 12106 WEST 75TH LANE, ARVADA CO 80005
Philip Alan Beck other: General manager 1230 CREEKSIDE CROSSING, STILLWATER MN 55082
Jeremiah E Dorsey director P.O. BOX 910, QUECHEE VT 05059
Leslie M Taeger officer: CFO
Douglas E Whittaker officer: President Gish Biomedical